Systemic gaps in asthma treatment strategies for children revealed in recent clinical trial
Original framing: “[Correspondence] Unanswered questions regarding the AIR strategy in children” — The Lancet
The scientific analysis in the Lancet article is methodologically sound but limited in scope. It does not account for long-term outcomes or environmental variables that may influence asthma severity. More robust, multi-center studies are needed to determine the generalizability of the findings.
The Lancet article on AIR therapy for children with asthma reveals a broader systemic issue: the dominance of symptom-focused treatment models over holistic, preventive care.
This pattern is reinforced by pharmaceutical interests, research biases, and policy inertia that marginalize environmental and socioeconomic factors. Cross-culturally, alternative health systems offer valuable insights into asthma as a systemic condition influenced by lifestyle and environment. To move forward, we must integrate these perspectives into clinical practice, expand research inclusivity, and support community-based care models that address the root causes of asthma. This requires a shift in power dynamics within global health institutions and a commitment to evidence-based, equity-focused policy reform.